Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Short hospital stay plus home care may help heart failure patients

NCT ID NCT04878263

Disease control Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times

Summary

This study tested a new care pathway for people hospitalized with acute heart failure. Instead of a standard hospital stay, some patients were discharged early (within 4 days) and received follow-up care at home from both hospital and private practice teams. The goal was to see if this approach was as safe as usual care and could reduce deaths or unplanned readmissions within 6 months. The study involved 361 adults and compared the two care methods.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
organized care pathway (short hospitalization followed by home care)
What this could lead to
If successful, this approach could improve recovery and reduce hospital readmissions for heart failure patients.
What could go wrong
This is a completed study, but results may not apply to all patients or settings. The intervention is a care process, not a new drug, so benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

361 people

The number who actually took part.

Started

Jun 2021

Finished

Dec 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient over 18 years old hospitalized for acute heart failure * Patient able to express his consent before participating in the study, certified by the caregiver if a written consent is not possible * Patient able to follow protocol procedures, alone or with a caregiver help * Caregiver consent to participate in the study and assist the patient during its own participation, if caregiver involvement is necessary * Patient requiring an hospitalisation of at least 24 hours * Patient covered by social security or equivalent regimen * Patient having access to a mobile of fixed phone line Exclusion Criteria: * Admission in intensive care or resuscitation unit AND need for inotropic support, vasodilator, or invasive/non-invasive ventilation for the last 24h * Renal insufficiency with CKD-EPI clearance inferior to 15 ml/min/1.73m2 since admission or dialysis * Patient planned transfer to a rehabilitation and recuperative care facility (hospital or nursing home) * Associated disease requiring frequent re-hospitalizations (cancer, dialysis, repeated sessions during planned hospitalizations) * Associated disease with a high risk of death for the next 6 months * Chronical respiratory insufficiency requiring daily invasive ventilation or a more than 3L/min permanent oxygen therapy * Patient suffering from severe dementia defined by a MMSE score ≤ 9 * Person participating in another research testing another care pathway * Every other reason which, according to investigator, might interfere with study objective assessment * Person under judicial protection measure (guardianship, curatorship) * Person deprived of liberty by a judicial or administrative decision

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart failure, acute are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart failure, acute

Contacts and locations

Locations

  • Centre Hospitalier Intercommunal Toulon La Seyne sur Mer

    Toulon, Var, 83100, France

  • Hôpital Sainte Anne

    Toulon, Var, 83000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.